News

Fierce Biotech2d
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...
BioPharma Dive2d
Sanofi gains experimental Alzheimer’s drug through Vigil buyout
Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing ...
NJBIZ22h
Sanofi’s $130M Morristown flagship puts people first
Sanofi relocated 2,000 employees to a new $130M Morristown flagship office at M Station West in May, leaving Bridgewater.
PharmTech1d
Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline
Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...
Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug
About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...
Fierce Pharma1d
Sanofi opens doors to $130M 'flagship' US office facility in New Jersey
In the wake of the COVID-19 pandemic, which acclimated many workers to at-home or hybrid work models, French drugmaker Sanofi ...
Explore more
Sanofi Redefines R&D strategy with AI: Vanguards of Health Care
Houman Ashrafian, Head of R&D at Sanofi. In this episode, Ashrafian joins Bloomberg Intelligence analyst Sam Fazeli to unpack how AI-powered portfolio construction, franchise-based innovation and a ...
New Jersey Business Magazine1d
Sanofi Opens $130M Offices in Morristown
Global healthcare company Sanofi yesterday formally opened its new flagship US offices at M Station West in Morristown.
Medical Dialogues7h
Sanofi Gets CDSCO Panel Nod to Update Aldurazyme Prescribing Information
The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to ...